Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 7,188,553 $ 40,750,133
Marketable securities 15,861,620 0
Accounts receivable 39,881 110,141
Prepaid research and development 1,117,616 107,000
Prepaid expenses and other current assets 163,452 1,502,725
Total current assets 24,371,122 42,469,999
Equipment and improvements, net 236,532 0
Right-of-use asset 328,643 0
Total assets 24,936,297 42,469,999
Current liabilities:    
Accounts payable 1,151,173 1,089,778
Lease obligation, current 145,836 0
Accrued expenses and other current liabilities 2,398,436 2,715,761
Notes payable 0 248,911
Total current liabilities 3,695,445 4,054,450
Lease obligations, net of current portion 205,451 0
Total liabilities 3,900,896 4,054,450
Commitments and contingencies (see Note 14)
Stockholders' equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized at December 31, 2022 and 2021; 0 shares issued and outstanding at December 31, 2022 and 2021 0 0
Common stock, $0.001 par value; 100,000,000 shares authorized; 25,227,051 and 25,155,198 shares issued and outstanding at December 31, 2022 and 2021 25,227 25,155
Additional paid-in capital 68,777,298 68,208,081
Accumulated other comprehensive income 104,718 0
Accumulated deficit (47,871,842) (29,817,687)
Total stockholders' equity 21,035,401 38,415,549
Total liabilities and stockholders' equity $ 24,936,297 $ 42,469,999